POWER THE COURSE OF FIGHTING DISEASES AND SAVING LIVES
Domain expertise, global resource, long-term capital
PORTFOLIO NEWS
GUANGZHOU, China, June 12, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (“Burning Rock”...SOMERSET, NJ – June 5, 2020 – Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a...NORTH CHICAGO, Ill. and BEIJING, June 1, 2020 - AbbVie Inc. (NYSE: ABBV), a global...May 15, 2020--Peijia Medical Limited (Peijia Medical, stock code: 9996) was officially listed on...SUZHOU, China and SHANGHAI, April 28, 2020 /PRNewswire/ -- Gracell Biotechnologies Co., Ltd. (...SAN DIEGO, April 2, 2020 /PRNewswire/ -- Ansun Biopharma, Inc., a clinical stage...YANTAI, China, April 2, 2020 /PRNewswire/ -- RemeGen recently announced the closing of...Abbisko Therapeutics, an innovative biopharmaceutical company based in Shanghai Zhangjiang High...More Posts
Company
Shanghai
Room2909-14, 168 Hubin Road, Huangpu District, Shanghai, China.
Hong Kong
Unit 902-904, Two ChinaChem Central, 26 Des Voeux Road Central, Hong Kong
US
2730 Sand Hill Road, Suite 130, Menlo Park, CA
All Posts
×
LillyAsiaVentures
Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.
http://user-assets.sxlcdn.com/images/315509/FnksTvTDur7jpExbqYminmtjWgoM.png?imageMogr2/strip/auto-orient/thumbnail/1200x630>/format/png